Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen ER randomized withdrawal study in multiple sclerosis spasticity
2016-001356-22Phase 3Completed
- Sponsor
- Sun Pharma Advanced Research Company
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) and Muscle spasm comparing Continued baclofen ER with Down-titration to placebo (2 arms). Primary endpoint: Treatment failure during double-blind randomized withdrawal. Started Apr 2016; status: completed.
02
Drugs
baclofen
03
Conditions
multiple sclerosis (MS)Muscle spasm
Beyond the preview
Go deeper on 2016-001356-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001356-22.